Authors of two recent studies comparing these tests say doctors need to be careful not to assume that these tests are providing a complete picture of a tumor’s genetic variants, when using them to select treatments for cancer patients. Read more . . .
Two widely used tests to analyze the genetics of tumors often don’t come to the same conclusions, according to head-to-head analyses.